Signaling by CSF1 (M-CSF) in myeloid cells
REACTOME PATHWAYThe Signaling by CSF1 (M-CSF) in myeloid cells pathway (Reactome ID: R-HSA-9680350) involves 13 genes and is affected by 38 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Signaling by CSF1 (M-CSF) in myeloid cells
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Dasatinib | — | 299 |
| 2 | Crizotinib | — | 298 |
| 3 | Sorafenib | — | 300 |
| 4 | tyrphostin ag 1478 | — | 4 |
| 5 | pictilisib | — | 25 |
| 6 | kenpaullone | — | 8 |
| 7 | Quercetin | — | 300 |
| 8 | alsterpaullone | — | 12 |
| 9 | Wortmannin | — | 300 |
| 10 | ly294002 | — | 11 |
| 11 | alpelisib | — | 227 |
| 12 | Sirolimus | — | 300 |
| 13 | Axitinib | — | 298 |
| 14 | Resveratrol | — | 298 |
| 15 | Afatinib | — | 297 |
| 16 | Niclosamide | — | 299 |
| 17 | egcg | — | 300 |
| 18 | sp600125 | — | 117 |
| 19 | torin 1 | — | 10 |
| 20 | Kaempferols | — | 300 |
| 21 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | — | 150 |
| 22 | Cladribine | — | 297 |
| 23 | Pioglitazone | — | 297 |
| 24 | Vemurafenib | — | 298 |
| 25 | Adenosine Monophosphate Adenine nucleotide containing | — | 300 |
| 26 | monorden | — | 8 |
| 27 | Rosmarinic Acid | — | 300 |
| 28 | Genistein | — | 300 |
| 29 | Acetic Acid Product of | — | 300 |
| 30 | Ku 0063794 [Supplementary Concept] | — | 7 |
| 31 | Budesonide | — | 1,000 |
| 32 | Methylene Blue | — | 200 |
| 33 | Flurandrenolone | — | 65 |
| 34 | Hexachlorophene | — | 300 |
| 35 | streptonigrin | — | 299 |
| 36 | Fingolimod Hydrochloride | — | 56 |
| 37 | Celecoxib | — | 295 |
| 38 | Dactinomycin | — | 297 |
About the Signaling by CSF1 (M-CSF) in myeloid cells Pathway
The Signaling by CSF1 (M-CSF) in myeloid cells pathway is catalogued in Reactome (ID: R-HSA-9680350) and involves 13 genes. In the BiohacksAI corpus, 38 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CSF1R, FYN, GRB2, HCK, INPPL1.